Carla Cobb, Pharm.D., BCPP
Carla Cobb is a psychiatric pharmacy specialist at RiverStone Health and the Montana Family Medicine Residency in Billings, Montana where she has practiced for over 15 years. She is Clinical Professor in Pharmacy Practice at the University of Montana. Carla graduated from the University of Manitoba and received her Pharm.D. from the University of Texas. She completed a residency in psychiatric pharmacy at the University of Texas and San Antonio State Hospital. She is board certified in psychiatric pharmacy. She is a founding member of the College of Psychiatric and Neurologic Pharmacists and a member of the drug utilization review board for Montana Medicaid. She has received numerous grants focused on expanding the role of the pharmacist in caring for people with psychiatric disorders. In 2013 she was awarded the Bowl of Hygeia for outstanding community service.
M. Lynn Crismon, Pharm.D., FCCP, BCCP
M. Lynn Crismon is Dean of The University of Texas College of Pharmacy and holder of the James T. Doluisio Regents Chair and the Behrens Centennial Professor in Pharmacy at The University of Texas College of Pharmacy. Dr. Crismon received his BS degree in Pharmacy from The University of Oklahoma College of Pharmacy and his Doctor of Pharmacy degree from a joint program of The University of Texas at Austin and The University of Texas Health Science Center at San Antonio. He completed residencies in pharmacy practice at the USPHS Gallup Indian Medical Center and in psychiatric pharmacy practice at The University of Texas and San Antonio State Hospital, and completed a National Endowment for the Humanities–funded summer fellowship in biomedical ethics at the Kennedy Institute for Ethics, at Georgetown University. He is a Diplomat of the American Board of Clinical Pharmacology, and board certified in psychiatric pharmacy by the Board of Pharmaceutical Specialties.
Prior to becoming dean his research and practice focused on evidence-based psychiatry and the development and evaluation of strategies to improve the pharmacotherapy and health outcomes of adults and children with severe and persistent mental disorders. He continues to work on efforts to improve the quality of mental health care for children and adolescents, including active collaboration with the Texas Department of Family and Protective Services and the REACH Institute in New York. He is passionate about teaching and teaches clinical psychopharmacology and therapeutics to UT Southwestern – Austin psychiatry residents as well as Pharm.D. students.
Igor Grant, M.D.
Igor Grant, M.D., is Distinguished Professor and Chair of the Department of Psychiatry at the University of California, San Diego School of Medicine. He directs the UCSD HIV Neurobehavioral Research Program, a multidisciplinary and interdepartmental program that focuses on the effects of HIV on the brain and behavior. As Director of the University of California Center for Medicinal Cannabis Research, Dr. Grant oversees clinical trials exploring the possible utility of cannabis compounds in the amelioration of certain severe manifestations of disease. Dr. Grant’s research has been supported by multiple NIH and VA awards, and has resulted in over 600 publications.
Thomas Kosten, M.D.
Following a successful 25 year tenure as professor and chief of Psychiatry at Yale University and VA Connecticut, Dr. Kosten joined the Michael E. DeBakey Veterans Affairs Medical Center (MEDVAMC) in July 2006, bringing over 30 years of exemplary Federal service; the majority of which has been with the Department of Veterans Affairs. Over the period 2006-2011, Dr. Kosten served as the Research Director of the VA national Substance Use Disorders Quality Enhancement Research Initiative (QUERI) program, fully revitalizing a research-to-practice implementation program to provide proven, cutting-edge treatment to improve the lives of veteran populations across the VA health care system. With a joint appointment at Baylor College of Medicine (BCM), Dr. Kosten is the JH Waggoner Chair & Professor of Psychiatry, Pharmacology, Neuroscience and Immunology & Pathology. He is also vice-Chair for Psychiatry and Co-director of the Dan L. Duncan Institute for Clinical and Translational Research (ICTR) at Baylor College of Medicine. His other key appointments are Distinguished Professor of Psychiatry at Peking University Medical School and Professor of Epidemiology and of Behavioral Sciences at MD Anderson Cancer Prevention Center. He established the Division of Addictions Psychiatry at Baylor and Yale and directs their NIH Medications Development Center for substance abuse.
Y.W. Francis Lam, Pharm.D., FCCP
Dr. Lam is Professor of Pharmacology at the University of Texas Health Science Center San Antonio. He is also the James O. Burke Endowed Centennial Fellow in Pharmacy and Clinical Associate Professor at the University of Texas at Austin. Dr. Lam received his B.Pharm. degree from University of Bradford, England, and Pharm.D. degree from University of Minnesota. He is an elected Fellow of the American College of Clinical Pharmacy and Councilor of the Pacific Rim Association of Clinical Pharmacogenetics, and currently serves on the editorial board of Current Pharmacogenomics and Personalized Medicine and two other journals. He is the leading editor of two books related to the Clinical Pharmacology discipline, the most recent one being “Pharmacogenomics: Challenges and Opportunities in Therapeutic Implementation”. Dr. Lam had served on the United States Pharmacopoeia as an elected member of the Pharmaceutical Analysis Expert Committee and the Food and Drug Administration as an appointed Advisory Committee member. He was a Past President of the American Chinese Pharmaceutical Association and former director of a clinical laboratory certified by the American College of Pathologists and CLIA regulations of DHSS.
Jane Maxwell, Ph.D.
Jane Maxwell, Ph.D., is a Senior Research Scientist at the University of Texas at Austin. She was with the State’s substance abuse agency for 30 years prior to joining the University of Texas 12 years ago. She serves on advisory panels to the the Food and Drug Administration’s Center for Drug Evaluation and Research and is a member of the National Institute on Drug Abuse's Community Epidemiology Work Group. Her research specialties include trends and patterns of substance abuse in Texas, nationally, and internationally. She has been investigator on grants from the National Institute on Drug Abuse to study patterns of methamphetamine use in the central Texas area, routes of administration of heroin, and is now principal investigator on a grant from the National Institute on Alcoholism and Alcohol Abuse to study factors in recidivism for impaired driving offenders.
Troy A. Moore, Pharm.D., M.S., BCPP
Troy A. Moore received his PharmD from the University of New Mexico College of Pharmacy in 2003. He subsequently attended the University of Texas at Austin College, receiving his Master of Science in Pharmacy in 2005 while completing a 2 year Psychiatric Pharmacy at the San Antonio State Hospital and the South Texas Veterans Health Care System (STVHCS). He joined the University of Texas Health Science Center at San Antonio Department of Psychiatry, Division of Schizophrenia and Related Disorders in 2005 and became Assistant Professor in 2007. He joined the STVHCS as Clinical Pharmacy Specialist in Psychiatry in 2010 where he serves the Substance Abuse and Domiciliary Programs. He is the author of numerous publications, including the Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2006 update. He is a reviewer for multiple psychiatric and pharmacy journals. He is currently is the Director of the ASHP accredited PGY-2 Psychiatric Pharmacy Residency at STVHCS, serves as the Member-at-Large on the Board of Director for the College of Psychiatric and Neurologic, and serves as a member of the Board of Pharmacy Specialties Specialty Council on Psychiatric Pharmacy.
Alan Peterson, PhD, ABPP
Dr. Peterson is a board certified clinical health psychologist, Professor, and Chief of the Division of Behavioral Medicine within the Department of Psychiatry and School of Medicine at the University of Texas Health Science Center at San Antonio. He is the Director of the STRONG STAR Consortium and the Consortium to Alleviate PTSD. These two consortia include over 150 research collaborators and 25 institutions worldwide. He served previously as the Chair of the Department of Psychology and the Director of the Clinical Health Psychology Postdoctoral Fellowship Program at Wilford Hall Medical Center. He retired from the U.S. Air Force in 2005 after 21 years of active duty service including deployments in support of Operations Noble Eagle, Enduring Freedom, and Iraqi Freedom. He has clinical and research expertise in the areas of PTSD, psychological resiliency, and military health psychology. He has over 300 scientific publications and presentations and has obtained over $100 million in peer-reviewed federal research funding.
Karen L. Rascati, Ph.D.
Karen L. Rascati, Ph.D., is the Eckerd/Turley Centennial Professor of Pharmacy at The University of Texas College of Pharmacy (UT-COP) and Research Faculty for the UT-COP Center for Pharmacoeconomic Studies. Her research interests include economic and outcomes evaluations for several disease states as well as for pharmacy services. She has conducted over 40 funded research projects and served on various grant review panels. Dr. Rascati has supervised 39 MS and 23 PhD graduate student projects. She has authored or co-authored more than 100 publications (including five textbook chapters) and more than 100 national and international presentations. Her textbook, Essentials of Pharmacoeconomics was published in 2008, and was translated into Portuguese in 2009. A second edition was published in 2013. It is utilized in most US Colleges of Pharmacy. Much of Dr. Rascati’s research has involved retrospective analysis using large databases (e.g., Texas Medicaid, Department of Defense (DoD), and the Medical Expenditure Panel Survey (MEPS)).
Stephen R. Saklad, Pharm.D., BCPP
Dr Saklad joined the faculty of The University of Texas College of Pharmacy and the staff of San Antonio State Hospital in 1979. He has focused on providing the excellent teaching and pharmaceutical care to improve the quality of life and function in the serious and persistently mentally ill. He wrote and successfully lobbied for the creation of a clinical research unit at San Antonio State Hospital funded by the Texas Legislature and governed by the College of Pharmacy, Department of Psychiatry and San Antonio State Hospital. He developed the first websites for The University of Texas College of Pharmacy in 1994 and the College of Psychiatric and Neurologic Pharmacists (CPNP) in 1997. He is Director of the University of Texas Psychiatric Pharmacy Program in San Antonio, Founding Member of CPNP, served on the CPNP Board of Directors, and was the founding senior editor of their journal, the Mental Health Clinician. He has served as the clinical chair of The University of Texas Psychiatric Pharmacotherapy Update since 2005. He has published articles and presented to many groups around the country on a variety of pharmacy and mental health related topics. He is a principal or co-investigator for several studies of the efficacy and adverse effects of Phase II, III, and IV psychotropic agents in schizophrenia, mood disorders, and other serious mental illnesses, as well as their pharmacokinetics and interactions. He has received several honors, most recently the Judith J. Saklad Memorial Award from CPNP in 2012 and Teaching Excellence Award from the UT College of Pharmacy in 2013.
Rajesh Tampi, M.D., MS, FAPA
Dr. Tampi is an Associate Professor (Tenure Track) of Psychiatry at the University of Texas, San Antonio. Most recently, he was an Associate Clinical Professor of Psychiatry at Yale University School of Medicine and the Director of Behavioral Health Services at Masonicare in Wallingford. He trained in Psychiatry at the University of Leeds in England and the University of Vermont in Burlington, Vermont. During his residency training in England, he also attained a Post Graduate Diploma in Clinical Psychiatry from the University in Leeds. He completed his Geriatric Psychiatry Fellowship at Yale University School of Medicine, New Haven, CT. Dr. Tampi was a recipient of the American Association for Geriatric Psychiatry, 2013-Clinician of the Year Award and the Geriatric Academic Career Award (GACA) instituted by the Department of Health and Human Services (DHHS). He has also received three ‘Outstanding Teaching Attending Award’ and the ‘Chairman’s Award’ for outstanding teaching, research, and clinical work from the Department of Psychiatry at Yale University School of Medicine. His research interests are the treatments for Alzheimer’s disease and behavioral disturbances in dementia and late life psychiatric disorders. He has been a principal investigator and a sub-investigator on various clinical-trails at Yale University School of Medicine. He has published over 50 articles in peer reviewed national and international journals on various topics in geriatric psychiatry. In addition, Dr. Tampi is a chief editor for three books in psychiatry. Dr. Tampi serves on the editorial board of various peer reviewed national and international journals in psychiatry and is a reviewer for over 20 journals including the American Journal of Geriatric Psychiatry, American Journal of Psychiatry, and the American Journal of Alzheimer’s Disease and other Dementias.
|The University of Texas at Austin College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.|
|Comments to: UTPharmacyCE@austin.utexas.edu
Download free PDF Reader | Download free MS Reader
©2012 College of Pharmacy, The University of Texas at Austin